Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues. 1998

J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
Institute for Genetics, University of Cologne, 50931 Cologne, Germany.

Hodgkin disease (HD) is characterized by a small number of malignant Hodgkin and Reed-Sternberg (H/RS) cells among a major population of nonmalignant cells. The analysis of H/RS cells has been hampered by their low frequency and fragility. Here, we describe the isolation of viable H/RS cells from HD affected tissues by high gradient magnetic cell sorting (MACS) according to expression of CD30. The cells were enriched to a purity of up to 50%. H/RS cells were distinguished from other CD30(+) cells by the expression of CD15, their size and granularity. No CD30/CD15 double-positive cells could be enriched from a lymph node affected by the lymphocyte predominant subtype of HD, activated lymph nodes or peripheral blood of healthy donors. For two cases of HD individual MACS-purified H/RS cells and H/RS cells micromanipulated from tissue sections of the same lymphoma specimens were analyzed for Ig gene rearrangements. In both cases, identical V gene rearrangements were amplified from both sources of H/RS cells, showing that H/RS cells were successfully enriched. Moreover, the finding that in both cases no additional Ig gene rearrangements other than the ones identified in the H/RS cells micromanipulated from tissue sections were amplified from the MACS-purified H/RS cells further supports the monoclonality of these cells throughout the affected lymph nodes. The isolation of viable H/RS cells ex vivo is prerequisite for a direct study of gene expression by those cells and of their interaction with cells in their vicinity.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
January 2017, Blood,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
January 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
February 1996, Lancet (London, England),
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
October 1994, Proceedings of the National Academy of Sciences of the United States of America,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
September 1978, The Journal of pathology,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
October 2002, Pathology,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
June 1999, Cancer treatment reviews,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
November 2020, Diagnostics (Basel, Switzerland),
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
January 1998, Annual review of immunology,
J Irsch, and S Nitsch, and M L Hansmann, and K Rajewsky, and H Tesch, and V Diehl, and A Jox, and R Küppers, and A Radbruch
May 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!